Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Jones

Showing results (171-180 of 226) with videos related to

Pageof 23
Sort By:
Bioinformatics (Oxford, England)|January 24, 2014
InterProScan 5: genome-scale protein function classificationPhilip Jones, David Binns, Hsin-Yu Chang, et al.
Journal of Medicinal Chemistry|October 31, 2009
Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumorsPhilip Jones, Sergio Altamura, Julia Boueres, et al.
JACC. Heart Failure|April 19, 2024
Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF TrialSenthil Selvaraj, Shachi Patel, Andrew J Sauer, et al.
Proteomics|August 24, 2006
Automated reprocessing pipeline for searching heterogeneous mass spectrometric data of the HUPO Brain Proteome Project pilot phaseChristian Stephan, Kai A Reidegeld, Michael Hamacher, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 12, 2018
Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disordersCaroline F Wright, Jeremy F McRae, Stephen Clayton, et al.
Circulation. Cardiovascular Interventions|March 7, 2026
Hospital-level Variability in NSTEMI Management: Findings from the NCDR Chest Pain-MI RegistryYasser M Sammour, John A Spertus, Nathaniel R Smilowitz, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
Identification of potent and selective MTH1 inhibitorsAlessia Petrocchi, Elisabetta Leo, Naphtali J Reyna, et al.
Proteomics|September 17, 2005
5th HUPO BPP Bioinformatics Meeting at the European Bioinformatics Institute in Hinxton, UK--Setting the analysis frameChristian Stephan, Michael Hamacher, Martin Blüggel, et al.
American Journal of Obstetrics & Gynecology MFM|February 11, 2024
Validation of a noninvasive cardiac output monitor in maternal cardiac disease: comparison of NICOM and transthoracic echocardiogramKaren L Florio, Emily M Williams, Darcy White, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2011
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2Olaf Kinzel, Anna Alfieri, Sergio Altamura, et al.
Pageof 23

Showing results (171-180 of 226) with videos related to

Sort By:
Pageof 23
Bioinformatics (Oxford, England)|January 24, 2014
InterProScan 5: genome-scale protein function classificationPhilip Jones, David Binns, Hsin-Yu Chang, et al.
Journal of Medicinal Chemistry|October 31, 2009
Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumorsPhilip Jones, Sergio Altamura, Julia Boueres, et al.
JACC. Heart Failure|April 19, 2024
Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF TrialSenthil Selvaraj, Shachi Patel, Andrew J Sauer, et al.
Proteomics|August 24, 2006
Automated reprocessing pipeline for searching heterogeneous mass spectrometric data of the HUPO Brain Proteome Project pilot phaseChristian Stephan, Kai A Reidegeld, Michael Hamacher, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 12, 2018
Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disordersCaroline F Wright, Jeremy F McRae, Stephen Clayton, et al.
Circulation. Cardiovascular Interventions|March 7, 2026
Hospital-level Variability in NSTEMI Management: Findings from the NCDR Chest Pain-MI RegistryYasser M Sammour, John A Spertus, Nathaniel R Smilowitz, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
Identification of potent and selective MTH1 inhibitorsAlessia Petrocchi, Elisabetta Leo, Naphtali J Reyna, et al.
Proteomics|September 17, 2005
5th HUPO BPP Bioinformatics Meeting at the European Bioinformatics Institute in Hinxton, UK--Setting the analysis frameChristian Stephan, Michael Hamacher, Martin Blüggel, et al.
American Journal of Obstetrics & Gynecology MFM|February 11, 2024
Validation of a noninvasive cardiac output monitor in maternal cardiac disease: comparison of NICOM and transthoracic echocardiogramKaren L Florio, Emily M Williams, Darcy White, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2011
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2Olaf Kinzel, Anna Alfieri, Sergio Altamura, et al.
Pageof 23